(Q37880700)

English

Unfractionated or low molecular weight heparin for induction of remission in ulcerative colitis: a Cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials

scientific article published on 25 May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

Unfractionated or low molecular weight heparin for induction of remission in ulcerative colitis: a Cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

inflammatory bowel diseases

0 references

systematic review

1 reference

based on heuristic

inferred from title

ulcerative colitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Nilesh Chande

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

John K MacDonald

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Josh J Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

John W D McDonald

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

publication date

25 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1979-1986

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Randomised controlled trial of azathioprine withdrawal in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Azathioprine in ulcerative colitis: final report on controlled therapeutic trial.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Infliximab for induction and maintenance therapy for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Thrombotic vascular risk factors in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Cerebral venous thrombosis and heparin-induced thrombocytopenia in an 18-year old male with severe ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Leukocytapheresis for ulcerative colitis: a comparative study of anticoagulant (nafamostat mesilate vs. dalteparin sodium) for reducing clinical complications

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Treatment of corticosteroid-resistant ulcerative colitis with heparin--a report of 16 cases.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Low molecular weight heparin as adjuvant therapy in active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Novel drug development opportunities for heparin.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21776

21 January 2018

Identifiers

10.1002/IBD.21776

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37880700&oldid=1754776933"